A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

Kate L. Weeks, Helen Kiriazis, Glenn D. Wadley, E. Masterman, Nicola M. Sergienko, A. Raaijmakers, Adam J. Trewin, Claudia A. Harmawan, Gunes S. Yildiz, Yingying Liu, Brian G. Drew, Paul Gregorevic, Lea M.D. Delbridge, Julie R. McMullen, Bianca C. Bernardo